Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding-Reference-Cited by-同舟云学术

Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding

Published:2018-12-04 Issue:5 Volume:184 Page:808-816
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Arachchillage Deepa R. J.¹²³^ORCID,Alavian Sharon¹,Griffin Jessica¹,Gurung Kamala¹,Szydlo Richard¹,Karawitage Nilanthi¹,Laffan Mike¹²

Affiliation:

1. Department of Haematology; Imperial College Healthcare NHS Trust Imperial College London; London UK

2. Centre for Haematology; Imperial College London; London UK

3. Department of Haematology; Royal Brompton Hospital; London UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15705/fullpdf

Reference29 articles.

1. Andexanet Alfa for acute major bleeding associated with factor Xa inhibitors;Connolly;The New England Journal of Medicine,2016

2. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis;Dentali;Thrombosis and Haemostasis,2011

3. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians;Douxfils;Journal of Thrombosis and Haemostasis,2018

4. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects;Eerenberg;Circulation,2011

5. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage;Gerner;Annals of Neurology,2018

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors;Journal of Thrombosis and Haemostasis;2024-08

2. Four-factor Prothrombin Complex Concentrate During Liver Transplantation: A Retrospective Cohort Study;Transplantation Direct;2024-05-16

3. The use of andexanet alpha in the Polish setting: An interdisciplinary protocol. Expert consensus statement of the Polish Cardiac Society;Kardiologia Polska;2024-01-31

4. Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants;Annals of Emergency Medicine;2023-09

5. Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing;Research and Practice in Thrombosis and Haemostasis;2023-02